Clin2
NCT06141538Possibly a fitNot yet recruiting

Anticoagulants for heart clot in atrial fibrillation

Atrial FibrillationIntracardiac Thrombus

Part of Heart & circulation clinical trials.

This study tests how well anticoagulant medicines dissolve blood clots in the heart of people with atrial fibrillation. It may help doctors choose the best treatment to prevent strokes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are between 18 and 80 years old
  • You have atrial fibrillation (irregular heartbeat)
  • You have a confirmed blood clot in your heart (found by an ultrasound test)
  • You have not taken any blood thinners for this clot yet
  • You do not have heart valve disease, bleeding disorders, or other conditions that increase bleeding risk

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06396299Recruiting
Atrial fibrillation blood thinner outcomes study

This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.

Bangkok, Bangkok
NCT06866665Not yet recruiting
Blood thinner choices for people with atrial fibrillation and heart disease

This study compares two blood-thinning medicines to see which works better for people who have both atrial fibrillation (irregular heartbeat) and heart disease. It aims to reduce the risk of heart attack or stroke while avoiding bleeding problems.

NCT04347187Recruiting
Long-term blood-thinner study for atrial fibrillation patients

This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.

Moscow
NCT04700826Recruiting· Phase 4
Preventing stroke, death, and memory decline in atrial fibrillation

This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.

Birmingham, West Midlands
NCT02741349Recruiting
Checking stroke and bleeding risks in atrial fibrillation

This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.

Paris
NCT07139301Recruiting
Timing of blood thinners after stroke clot removal in atrial fibrillation

This study aims to find the best time to start blood thinners after emergency clot removal in people with atrial fibrillation who had a stroke. It may help reduce the risk of another stroke or bleeding.

Ma’anshan, Anhui

Hear when a new Atrial fibrillation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.